GPT and Hepatic steatosis: Compared with NASH Recip mice, the (NASH + DSF) Recip mice showed significantly reduced levels of serum ALT, serum AST, hepatic TG, liver index (%), hepatic steatosis, lobular inflammation and hepatic fibrosis (Supplementary Fig. 3b–f).